Alan Lee Bazaar - 18 Dec 2023 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Kimberley A. Elting, attorney-in-fact
Issuer symbol
OFIX
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
4
Filing time
20 Dec 2023, 16:39:45 UTC
Previous filing
14 Dec 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Disposed to Issuer $0 -8,936 -100% $0.000000* 0 18 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OFIX Stock Option (right to buy) Award $0 +47,652 $0.000000 47,652 18 Dec 2023 Common Stock 47,652 $13.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the stock option grant described in Table II below, the Board of the Issuer cancelled the deferred stock unit grant previously made to reporting person on December 12, 2023.
F2 The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023.